Pharma Leadership: Cultivating Talent in Uncertain Times

11/08/2021 By Andrea

Article contributed to PharmaLeaders and authored by: Beth Doladee, M.A., M.B.A., Managing Consultant and Neelima Paranjpey, Ph.D., Managing Consultant, The Vaya Group Executive Summary Today’s highly dynamic, fast-paced pharmaceutical industry requires knowledge preservation and leaders who understand these unique challenges. This means developing leadership from within, to preserve intellectual capital and ensure the right skills […]

Deciphering Complex Lab Data With Machine Learning

07/26/2021 By Andrea

Authored and contributed to PharmaLeaders by Jason Bhan, MD Accurate analysis of healthcare data is critical for research, delivery of care, treatment variability, and improving patient outcomes. The ability to identify patterns in real-world data (RWD) demands insights with faster speeds, greater specificity, and improved accuracy. And the challenges are increasing as more healthcare data […]

EMA begins rolling review of Valneva’s Covid-19 vaccine candidate VLA2001

12/08/2021

Valneva stated that it is now focused on securing regulatory approvals for VLA2001 after the positive results from the Phase III trial. The firm also added that it The post EMA begins rolling review of Valneva’s Covid-19 vaccine candidate VLA2001 appeared first on Pharmaceutical Business review. … [Read More...]

Merck signs agreement with Thermo Fisher Scientific to manufacture molnupiravir

12/08/2021

This deal is part of Merck’s commitment to make the drug available across the globe, following approval for use by regulatory bodies. Merck, in collaboration with Ridgeback Biotherapeutics, The post Merck signs agreement with Thermo Fisher Scientific to manufacture molnupiravir appeared first on … [Read More...]

Arbutus discovers molecular targets to treat Covid-19

12/08/2021

Canadian biopharmaceutical firm Arbutus Biopharma has identified many molecules that can inhibit the SARS-CoV-2 nsp5 main protease (Mpro), achieving its first milestone under Covid-19 discovery research and license The post Arbutus discovers molecular targets to treat Covid-19 appeared first on … [Read More...]

Sanofi agrees to buy Austria-based Origimm Biotechnology

12/07/2021

Financial details of the deal have not been disclosed. This deal is part of Sanofi’s strategy to explore growth opportunities and build a vaccines pipeline. The transaction will The post Sanofi agrees to buy Austria-based Origimm Biotechnology appeared first on Pharmaceutical Business review. … [Read More...]

Featured Article

Pharma Leadership: Cultivating Talent in Uncertain Times

Deciphering Complex Lab Data With Machine Learning

White Papers

Balancing Innovation and Risk Management in Biopharma Commercialization

Whitepaper: Execute a 5-Step Framework for Data Compliance in Healthcare Marketing in the 2020s

Industry News

EMA begins rolling review of Valneva’s Covid-19 vaccine candidate VLA2001

Merck signs agreement with Thermo Fisher Scientific to manufacture molnupiravir

Arbutus discovers molecular targets to treat Covid-19

Sanofi agrees to buy Austria-based Origimm Biotechnology